Skip to NavigationSkip to content

Pharmafile - Business Services News

The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between the ages of 12 and 13 (...
Angel Pharmaceuticals has received approval for their IND application, from the Center for Drug Evaluation (CDE) of the China National Medical...
The University of Texas MD Anderson Cancer Center has reported that Serial radiation therapy as monotherapy is a safe and effective noninvasive...
ViiV Healthcare, the global specialist HIV company, have presented positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine),...
The FDA has approved Vitti Labs’ Investigational New Drug (IND) application to conduct Phase II Clinical Trials using a combination of mesenchymal...
UK Ministers are considering the implementation of a COVID ‘Plan C’. Cabinet Office officials are said to be discussing proposals which could form...
Open Orphan has announced that they are progressing with their government-backed COVID-19 vaccine human challenge study.
Novartis announced today that it has signed an initial agreement with BioNTech SE to expand its support of the fill-and-finish of the Pfizer-BioNTech...
Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its lead N,N-dimethyltryptamine (DMT)...
Precision oncology company, Anticancer Bioscience (ACB), has announced that it has secured an additional $10.6 million from Chinese investors. 
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches